Global Apheresis Equipment Market is valued at approximately USD 2.66 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2024-2032. Apheresis equipment is a medical technology used for a procedure called apheresis, which involves the separation and collection of specific components of blood. This equipment typically includes a machine with specialized tubing sets and filters that allow for the separation of blood into its various components, such as red blood cells, plasma, platelets, and white blood cells. These devices are designed to ensure the safe and efficient collection of specific blood components for therapeutic purposes, such as treating certain medical conditions or preparing blood products for transfusion. The Apheresis Equipment market is expanding because of factors such as the rising prevalence of blood-related disorders, rising popularity & participation in blood donation drives & camps, and favorable government initiatives along with reimbursement frameworks.

Chronic myeloid leukemia (CML) is a type of blood cancer that affects the bone marrow, leading to the overproduction of abnormal white blood cells. In some cases, patients with CML may require stem cell transplants as part of their treatment regimen. Apheresis equipment plays a crucial role in the collection of hematopoietic stem cells from donors or patients for transplantation. As the prevalence of CML increases, so does the demand for stem cell transplants, thereby driving the need for apheresis equipment. According to the Leukemia & Lymphoma Society (LLS) 2021, approximately every three minutes, one person in the United States is diagnosed with blood cancer. The new cases of leukemia, lymphoma, and myeloma accounted for 9.8% of the total 1,898,160 new cancer cases diagnosed in the United States in 2021. Moreover, according to the National Library of Medicine, the prevalence of chronic myeloid leukemia (CML) across the globe was 112,000 in the year 2020, and it is projected to increase to 144,000 by the year 2030, and 167,000 by the year 2040 and 181,000 cases by the year 2050. The rising prevalence of chronic myeloid leukemia across the globe is driving the market growth. In addition, rising R&D investments by biopharmaceutical companies and the growing field of regenerative medicine are some factors creating new opportunities for market growth. However, the high cost of apheresis equipment and stringent regulatory requirements stifle market growth throughout the forecast period of 2024-2032.

The key regions considered for the Global Apheresis Equipment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the widespread occurrence of blood-related disorders and the need for blood components. Primary users encompass hospitals, clinics, and blood donation centers. Leading market players such as B. Braun Melsungen AG, Haemonetics Corp., and Fresenius Kabi AG are actively engaged in mergers and acquisitions to consolidate their positions. Within North America, the U.S. stands out as a dominant force owing to its advanced healthcare infrastructure. Anticipated trends include ongoing technological innovations and heightened awareness initiatives, which are poised to sustain market expansion. Asia Pacific is expected to grow at the fastest during the forecast period, owing to factors such as escalating incidence of blood disorders necessitating plasma and platelet transfusions in emerging economies like India and China underscores the growth trajectory. Furthermore, the enhancement of healthcare infrastructure and the rising count of healthcare professionals in these regions are poised to provide a solid foundation for substantial industry expansion throughout the forecast period.

Major market players included in this report are:
B. Braun Melsungen AG
Haemonetics Corporation
Fresenius Kabi AG
Asahi Kasei Medical Co., Ltd.
Terumo BCT, Inc.
Mallinckrodt Plc
Nikkiso Europe GmbH
Medicap clinic GmbH
Medica SPA
Kawasumi Laboratories, Inc
Recent Developments in the Market:
In August 2023, TERUMO BCT, INC. received clearance from the U.S. FDA for its platelet device, which streamlines blood processing into platelets within a single centrifugation cycle.
In August 2023, Fresenius Kabi AG and Lupagen Inc. signed a supply and development pact aimed at advancing technologies tailored to facilitate the delivery of cell and gene therapies directly to the patient's bedside.
Global Apheresis Equipment Market Report Scope:
Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2024-2032
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Procedure, Technology, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the market's future. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Disposable Apheresis Kits
Devices
By Application:
Renal Diseases
Hematology
Neurology
Others
By Procedure:
Plasmapheresis
Photopheresis
Leukapheresis
Plateletpheresis
LDL Apheresis
Erythrocytapheresis
Others
By Technology:
Membrane Filtration
Centrifugation
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa